RARE Ultragenyx Pharmaceutical Inc.
Nasdaq · SEC CIK 1515673 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $3.95M 25 sales by 9 insiders
- Filings on record
- 172 since 2021-07-08, latest 2026-09-15 18:57
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Horn Howard | CFO | — | $1.33M |
| KAKKIS EMIL D | Pres, CEO, Dir | — | $1.24M |
| Parschauer Karah Herdman | EVP, CLO | — | $487.9K |
| Harris Erik | EVP, Chief Commercial Off | — | $240.3K |
| Pinion John Richard | See Remarks | — | $228.7K |
| Crombez Eric | EVP, Chief Medical Off | — | $168.8K |
| SULIMAN SHEHNAAZ | Dir | — | $144.2K |
| Huizenga Theodore Alan | SVP, CAO | — | $59.8K |
| Sanders Corazon (Corsee) D. | Dir | — | $50.1K |
| Ray Amrit | Dir | — | — |
Transactions 235
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-09-15 18:57 | 2026-09-15 | RARE | Huizenga Theodore Alan | SVP, CAO | S - Sale | $13.57 | -1,283 | 67.9K | -2% | -$17.4K |
| 2026-09-08 12:29 | 2026-09-03 | RARE | Huizenga Theodore Alan | SVP, CAO | S - Sale | $13.99 | -161 | 69.1K | -0.2% | -$2,252 | |
| T | 2026-08-04 15:15 | 2026-08-03 | RARE | Parschauer Karah Herdman | EVP, CLO | S - Sale | $24.92 | -1,900 | 92.6K | -2% | -$47.3K |
| T | 2026-08-04 15:13 | 2026-08-03 | RARE | Horn Howard | CFO | S - Sale | $24.92 | -4,696 | 96.3K | -5% | -$117.0K |
| T | 2026-07-06 15:37 | 2026-07-01 | RARE | Horn Howard | CFO | S - Sale | $33.13 | -4,698 | 101.0K | -4% | -$155.6K |
| 2026-06-15 18:50 | 2026-06-15 | RARE | Sanders Corazon (Corsee) D. | Dir | S - Sale | $25.05 | -2,000 | 21.1K | -9% | -$50.1K | |
| T | 2026-06-15 18:46 | 2026-06-15 | RARE | Parschauer Karah Herdman | EVP, CLO | S - Sale | $24.62 | -1,899 | 94.5K | -2% | -$46.8K |
| T | 2026-06-01 19:11 | 2026-06-01 | RARE | Horn Howard | CFO | S - Sale | $23.77 | -4,653 | 105.7K | -4% | -$110.6K |
| D | 2026-05-18 18:50 | 2026-05-14 | RARE | Fust Matthew K | Dir | A - Grant | $0.00 | +7,751 | 33.7K | +30% | $0 |
| DT | 2026-05-18 18:41 | 2026-05-14 | RARE | SULIMAN SHEHNAAZ | Dir | A - Grant | $0.00 | +7,751 | 33.7K | +30% | $0 |
| DT | 2026-05-18 18:41 | 2026-05-18 | RARE | SULIMAN SHEHNAAZ | Dir | S - Sale | $25.12 | -5,740 | 28.0K | -17% | -$144.2K |
| D | 2026-05-18 18:39 | 2026-05-14 | RARE | Ray Amrit | Dir | A - Grant | $0.00 | +7,751 | 31.1K | +33% | $0 |
| D | 2026-05-18 18:38 | 2026-05-14 | RARE | Sanders Corazon (Corsee) D. | Dir | A - Grant | $0.00 | +7,751 | 23.1K | +51% | $0 |
| D | 2026-05-18 18:35 | 2026-05-14 | RARE | NARACHI MICHAEL | Dir | A - Grant | $0.00 | +7,751 | 40.4K | +24% | $0 |
| D | 2026-05-18 18:23 | 2026-05-14 | RARE | WELCH DANIEL G | Dir | A - Grant | $0.00 | +7,751 | 40.4K | +24% | $0 |
| D | 2026-05-18 18:21 | 2026-05-14 | RARE | Dunsire Deborah | Dir | A - Grant | $0.00 | +7,751 | 38.6K | +25% | $0 |
| 2026-05-06 14:51 | 2026-05-05 | RARE | Crombez Eric | EVP, Chief Medical Off | S - Sale | $24.96 | -344 | 111.2K | -0.3% | -$8,586 | |
| T | 2026-05-04 17:35 | 2026-05-01 | RARE | Horn Howard | CFO | S - Sale | $24.90 | -4,683 | 110.3K | -4% | -$116.6K |
| D | 2026-04-24 16:39 | 2026-04-22 | RARE | Huizenga Theodore Alan | SVP, CAO | A - Grant | $0.00 | +20.2K | 68.9K | +42% | $0 |
| D | 2026-04-20 17:19 | 2026-04-16 | RARE | KAKKIS EMIL D | Pres, CEO, Dir | A - Grant | $0.00 | +76.7K | 735.7K | +12% | $0 |
| D | 2026-04-20 17:17 | 2026-04-16 | RARE | Huang Dennis Karl | See Remarks | A - Grant | $0.00 | +23.1K | 147.8K | +19% | $0 |
| D | 2026-04-20 17:16 | 2026-04-16 | RARE | Pinion John Richard | See Remarks | A - Grant | $0.00 | +23.1K | 133.1K | +21% | $0 |
| D | 2026-04-20 17:15 | 2026-04-16 | RARE | Parschauer Karah Herdman | EVP, CLO | A - Grant | $0.00 | +28.9K | 95.7K | +43% | $0 |
| D | 2026-04-20 17:13 | 2026-04-16 | RARE | Harris Erik | EVP, Chief Commercial Off | A - Grant | $0.00 | +28.9K | 118.4K | +32% | $0 |
| D | 2026-04-20 17:11 | 2026-04-16 | RARE | Crombez Eric | EVP, Chief Medical Off | A - Grant | $0.00 | +34.7K | 111.0K | +45% | $0 |
| D | 2026-04-20 17:09 | 2026-04-16 | RARE | Horn Howard | CFO | A - Grant | $0.00 | +34.7K | 115.0K | +43% | $0 |
| T | 2026-04-02 18:19 | 2026-04-01 | RARE | Horn Howard | CFO | S - Sale | $20.97 | -4,683 | 80.4K | -6% | -$98.2K |
| M | 2026-03-10 | 2026-03-06+ | RARE | Parschauer Karah Herdman | EVP, CLO | S - Sale | $21.87 | -9,526 | 70.3K | -12% | -$208.3K |
| 2026-03-03 | 2026-03-01 | RARE | Pinion John Richard | See Remarks | A - Grant | $0.00 | +11.1K | 119.6K | +10% | $0 | |
| 2026-03-03 | 2026-03-02 | RARE | Pinion John Richard | See Remarks | S - Sale | $22.80 | -10.0K | 110.0K | -8% | -$228.7K | |
| 2026-03-03 | 2026-03-01 | RARE | Crombez Eric | EVP, Chief Medical Off | A - Grant | $0.00 | +11.6K | 83.2K | +16% | $0 | |
| 2026-03-03 | 2026-03-02 | RARE | Crombez Eric | EVP, Chief Medical Off | S - Sale | $22.80 | -7,029 | 76.3K | -8% | -$160.3K | |
| 2026-03-03 | 2026-03-01 | RARE | Parschauer Karah Herdman | EVP, CLO | A - Grant | $0.00 | +11.1K | 84.4K | +15% | $0 | |
| 2026-03-03 | 2026-03-02 | RARE | Parschauer Karah Herdman | EVP, CLO | S - Sale | $22.80 | -8,135 | 76.3K | -10% | -$185.5K | |
| 2026-03-03 | 2026-03-01 | RARE | Harris Erik | EVP, Chief Commercial Off | A - Grant | $0.00 | +11.6K | 99.5K | +13% | $0 | |
| 2026-03-03 | 2026-03-02 | RARE | Harris Erik | EVP, Chief Commercial Off | S - Sale | $22.80 | -10.5K | 89.5K | -11% | -$240.3K | |
| 2026-03-03 | 2026-03-02 | RARE | Huizenga Theodore Alan | SVP, CAO | S - Sale | $22.80 | -1,632 | 48.7K | -3% | -$37.2K | |
| 2026-03-03 | 2026-03-02 | RARE | Huizenga Theodore Alan | SVP, CAO | F - Tax | $23.39 | -148 | 50.3K | -0.3% | -$3,462 | |
| 2026-03-03 | 2026-03-02 | RARE | Huang Dennis Karl | See Remarks | F - Tax | $23.39 | -999 | 124.7K | -0.8% | -$23.4K | |
| 2026-03-03 | 2026-03-01 | RARE | Huang Dennis Karl | See Remarks | A - Grant | $0.00 | +11.1K | 125.7K | +10% | $0 | |
| 2026-03-03 | 2026-03-02 | RARE | KAKKIS EMIL D | Pres, CEO, Dir | S - Sale | $22.80 | -54.4K | 659.0K | -8% | -$1.24M | |
| 2026-03-03 | 2026-03-01 | RARE | KAKKIS EMIL D | Pres, CEO, Dir | A - Grant | $0.00 | +71.2K | 712.9K | +11% | $0 | |
| MT | 2026-03-03 | 2026-03-02+ | RARE | Horn Howard | CFO | S - Sale | $22.65 | -10.0K | 86.7K | -10% | -$227.5K |
| T | 2026-03-03 | 2026-03-01 | RARE | Horn Howard | CFO | A - Grant | $0.00 | +6,143 | 95.1K | +7% | $0 |
| T | 2026-02-03 | 2026-02-02 | RARE | Horn Howard | CFO | S - Sale | $23.56 | -3,061 | 88.9K | -3% | -$72.1K |
| T | 2026-01-05 | 2026-01-02 | RARE | Horn Howard | CFO | S - Sale | $22.84 | -3,150 | 92.0K | -3% | -$71.9K |
| 2025-12-30 | 2025-12-29 | RARE | Huizenga Theodore Alan | SVP, CAO | S - Sale | $34.38 | -85 | 50.5K | -0.2% | -$2,922 | |
| T | 2025-12-11 | 2025-12-10 | RARE | Horn Howard | CFO | S - Sale | $36.38 | -3,081 | 95.1K | -3% | -$112.1K |
| 2025-10-14 | 2025-10-13 | RARE | Horn Howard | CFO | S - Sale | $31.51 | -7,942 | 98.2K | -7% | -$250.3K | |
| 2025-09-19 | 2025-09-18 | RARE | Huizenga Theodore Alan | SVP, CAO | S - Sale | $29.17 | -64 | 50.2K | -0.1% | -$1,867 | |
| 2025-09-12 | 2025-09-12 | RARE | Parschauer Karah Herdman | EVP, CLO | S - Sale | $31.17 | -2,450 | 73.3K | -3% | -$76.4K | |
| 2025-09-08 | 2025-09-05 | RARE | Huizenga Theodore Alan | SVP, CAO | S - Sale | $31.39 | -84 | 50.3K | -0.2% | -$2,637 | |
| T | 2025-06-23 | 2025-06-20 | RARE | Sanders Corazon (Corsee) D. | Dir | S - Sale | $37.39 | -2,405 | 15.3K | -14% | -$89.9K |
| D | 2025-05-19 | 2025-05-15 | RARE | WELCH DANIEL G | Dir | A - Grant | $0.00 | +5,740 | 32.7K | +21% | $0 |
| D | 2025-05-19 | 2025-05-15 | RARE | Ray Amrit | Dir | A - Grant | $0.00 | +5,740 | 23.4K | +33% | $0 |
| D | 2025-05-19 | 2025-05-15 | RARE | Dunsire Deborah | Dir | A - Grant | $0.00 | +5,740 | 30.8K | +23% | $0 |
| D | 2025-05-19 | 2025-05-15 | RARE | NARACHI MICHAEL | Dir | A - Grant | $0.00 | +5,740 | 32.7K | +21% | $0 |
| D | 2025-05-19 | 2025-05-15 | RARE | Sanders Corazon (Corsee) D. | Dir | A - Grant | $0.00 | +5,740 | 17.7K | +48% | $0 |
| D | 2025-05-19 | 2025-05-15 | RARE | SULIMAN SHEHNAAZ | Dir | A - Grant | $0.00 | +5,740 | 25.9K | +28% | $0 |
| D | 2025-05-19 | 2025-05-15 | RARE | Fust Matthew K | Dir | A - Grant | $0.00 | +5,740 | 25.9K | +28% | $0 |
| M | 2025-05-05 | 2025-04-21+ | RARE | Crombez Eric | EVP, Chief Medical Off | S - Sale | $37.93 | -762 | 71.7K | -1% | -$28.9K |
| 2025-03-10 | 2025-03-06 | RARE | Horn Howard | CFO | S - Sale | $40.40 | -1,785 | 106.2K | -2% | -$72.1K | |
| D | 2025-03-04 | 2025-03-03 | RARE | Huizenga Theodore Alan | SVP, CAO | S - Sale | $42.10 | -967 | 50.3K | -2% | -$40.7K |
| D | 2025-03-04 | 2025-03-03 | RARE | Huizenga Theodore Alan | SVP, CAO | F - Tax | $42.92 | -141 | 50.1K | -0.3% | -$6,052 |
| D | 2025-03-04 | 2025-03-01 | RARE | Huizenga Theodore Alan | SVP, CAO | A - Grant | $0.00 | +9,392 | 51.2K | +22% | $0 |
| DTI | 2025-03-04 | 2025-02-28 | RARE | KAKKIS EMIL D | Pres, CEO, Dir | S - Sale | $42.48 | -25.0K | 2.16M | -1% | -$1.06M |
| DMT | 2025-03-04 | 2025-03-01 | RARE | KAKKIS EMIL D | Pres, CEO, Dir | A - Grant | $0.00 | +150.6K | 607.9K | +33% | $0 |
| DT | 2025-03-04 | 2025-03-03 | RARE | KAKKIS EMIL D | Pres, CEO, Dir | S - Sale | $42.10 | -73.4K | 641.7K | -10% | -$3.09M |
| DM | 2025-03-04 | 2025-03-01 | RARE | Huang Dennis Karl | See Remarks | A - Grant | $0.00 | +32.9K | 97.5K | +51% | $0 |
| D | 2025-03-04 | 2025-03-03 | RARE | Huang Dennis Karl | See Remarks | F - Tax | $42.92 | -1,348 | 114.6K | -1% | -$57.9K |
| DM | 2025-03-04 | 2025-03-01 | RARE | Pinion John Richard | See Remarks | A - Grant | $0.00 | +32.9K | 122.2K | +37% | $0 |
| D | 2025-03-04 | 2025-03-03 | RARE | Pinion John Richard | See Remarks | S - Sale | $42.10 | -14.4K | 107.8K | -12% | -$607.9K |
| D | 2025-03-04 | 2025-03-03 | RARE | Pinion John Richard | See Remarks | F - Tax | $42.92 | -31 | 108.4K | -0.0% | -$1,331 |
| 2025-03-04 | 2025-03-03 | RARE | Kassberg Thomas Richard | EVP, CBO | F - Tax | $42.92 | -508 | 264.7K | -0.2% | -$21.8K | |
| 2025-03-04 | 2025-03-01 | RARE | Kassberg Thomas Richard | EVP, CBO | A - Grant | $0.00 | +18.4K | 271.3K | +7% | $0 | |
| 2025-03-04 | 2025-03-03 | RARE | Kassberg Thomas Richard | EVP, CBO | S - Sale | $42.10 | -6,028 | 265.2K | -2% | -$253.8K | |
| 2025-03-04 | 2025-03-03 | RARE | Parschauer Karah Herdman | EVP, CLO | S - Sale | $42.10 | -12.8K | 75.3K | -15% | -$540.8K | |
| 2025-03-04 | 2025-03-01 | RARE | Parschauer Karah Herdman | EVP, CLO | A - Grant | $0.00 | +18.4K | 88.1K | +26% | $0 | |
| DM | 2025-03-04 | 2025-03-01 | RARE | Crombez Eric | EVP, Chief Medical Off | A - Grant | $0.00 | +31.8K | 65.2K | +95% | $0 |
| D | 2025-03-04 | 2025-03-03 | RARE | Crombez Eric | EVP, Chief Medical Off | S - Sale | $42.10 | -8,945 | 71.9K | -11% | -$376.6K |
| DM | 2025-03-04 | 2025-03-01 | RARE | Harris Erik | EVP, Chief Commercial Off | A - Grant | $0.00 | +35.3K | 84.0K | +72% | $0 |
| D | 2025-03-04 | 2025-03-03 | RARE | Harris Erik | EVP, Chief Commercial Off | S - Sale | $42.10 | -15.1K | 87.9K | -15% | -$635.8K |
| D | 2025-03-04 | 2025-03-01 | RARE | Horn Howard | CFO | A - Grant | $0.00 | +15.7K | 108.0K | +17% | $0 |
| DM | 2025-03-03 | 2025-02-27 | RARE | Parschauer Karah Herdman | EVP, CLO | S - Sale | $42.88 | -2,990 | 55.0K | -5% | -$128.2K |
| D | 2025-03-03 | 2025-03-01 | RARE | Parschauer Karah Herdman | EVP, CLO | A - Grant | $0.00 | +14.5K | 69.7K | +26% | $0 |
| TI | 2024-12-31 | 2024-12-30 | RARE | KAKKIS EMIL D | Pres, CEO, Dir | S - Sale | $42.23 | -11.7K | 2.18M | -0.5% | -$495.2K |
| 2024-12-11 | 2024-12-10 | RARE | Huizenga Theodore Alan | SVP, CAO | G - Gift | $0.00 | -648 | 41.8K | -2% | $0 | |
| TI | 2024-12-11 | 2024-12-09 | RARE | KAKKIS EMIL D | Pres, CEO, Dir | G - Gift | $0.00 | -20.0K | 2.20M | -0.9% | $0 |
| TI | 2024-12-11 | 2024-12-10 | RARE | KAKKIS EMIL D | Pres, CEO, Dir | S - Sale | $50.00 | -8,273 | 2.20M | -0.4% | -$413.6K |
| 2024-10-11 | 2024-10-10 | RARE | Horn Howard | CFO | S - Sale | $52.76 | -7,465 | 92.3K | -7% | -$393.9K | |
| 2024-09-18 | 2024-09-16 | RARE | Huizenga Theodore Alan | SVP, CAO | A - Grant | $0.00 | +700 | 42.3K | +2% | $0 | |
| TI | 2024-09-05 | 2024-09-03 | RARE | KAKKIS EMIL D | Pres, CEO, Dir | S - Sale | $55.85 | -20.0K | 2.22M | -0.9% | -$1.12M |
| 2024-09-05 | 2024-09-03 | RARE | Huizenga Theodore Alan | SVP, CAO | S - Sale | $56.19 | -91 | 41.6K | -0.2% | -$5,113 | |
| TI | 2024-08-07 | 2024-08-06 | RARE | KAKKIS EMIL D | Pres, CEO, Dir | S - Sale | $50.17 | -20.0K | 2.24M | -0.9% | -$1.00M |
| T | 2024-07-03 | 2024-07-02 | RARE | Sanders Corazon (Corsee) D. | Dir | S - Sale | $40.98 | -584 | 12.0K | -5% | -$23.9K |
| D | 2024-06-20 | 2024-06-18 | RARE | NARACHI MICHAEL | Dir | A - Grant | $0.00 | +5,345 | 26.9K | +25% | $0 |
| D | 2024-06-20 | 2024-06-18 | RARE | SULIMAN SHEHNAAZ | Dir | A - Grant | $0.00 | +5,345 | 20.2K | +36% | $0 |
| D | 2024-06-20 | 2024-06-18 | RARE | WELCH DANIEL G | Dir | A - Grant | $0.00 | +5,345 | 26.9K | +25% | $0 |
| D | 2024-06-20 | 2024-06-18 | RARE | Fust Matthew K | Dir | A - Grant | $0.00 | +5,345 | 20.2K | +36% | $0 |
| D | 2024-06-20 | 2024-06-18 | RARE | Ray Amrit | Dir | A - Grant | $0.00 | +5,345 | 17.6K | +44% | $0 |
Purchase Sale Sale after option exercise All abbreviations